Huajian Medical reached a cooperation with Renhe International to jointly build a vertical RWA exchange focusing on the field of over-the-counter drugs

According to Foresight News, the Hong Kong-listed company Huajian Medical issued an announcement that the group and Renhe International, an indirect wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd., have reached a strategic cooperation to jointly establish the world's first vertical RWA exchange focused on the field of over-the-counter drugs in the United States.
Disclaimer: The views in this article only represent the author's personal views and do not constitute investment advice of this platform. This platform does not make any guarantees for the accuracy, completeness, originality and timeliness of article information, nor is it liable for any losses caused by the use or trust in article information.